We are live on ! Find out more
MESO

Mesoblast

53 hedge funds and large institutions have $24.3M invested in Mesoblast in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

4% more funds holding

Funds holding: 5153 (+2)

0.03% less ownership

Funds ownership: 0.28%0.25% (-0.03%)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

60% less capital invested

Capital invested by funds: $61.1M → $24.3M (-$36.9M)

65% less call options, than puts

Call options by funds: $3.2M | Put options by funds: $9.18M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
0.93%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
13
Reduced
16
Closed
11
Calls
$3.2M
Puts
$9.18M
Net Calls
-$5.97M
Net Calls Change
+$43.5M

MESO Hedge Fund Activity: Q4 2020 in Review

53 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q4 2020, worth a combined $24.3M — down 60% from $61.1M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new MESO positions and 11 closed out — a net gain of 2 holders — while 13 added to existing stakes and 16 trimmed.

The largest buyer was Bank of America, adding an estimated $2.73M. The largest seller was Susquehanna International Group, cutting an estimated $4.15M.

  • 53 institutional investors held Mesoblast (MESO) as of Q4 2020, up from 51 in Q3 2020.
  • Funds reported $24.3M of Mesoblast stock for Q4 2020, down 60% quarter-over-quarter.
  • 13 funds opened new Mesoblast positions in Q4 2020 and 11 closed out, a net change of +2 holders.
  • The largest Mesoblast buyer in Q4 2020 was Bank of America, an estimated $2.73M added.
  • The largest Mesoblast seller in Q4 2020 was Susquehanna International Group, an estimated $4.15M sold.

Based on aggregated 13F filings for Q4 2020.